Journal article
Control of Hypertension In Pregnancy Study randomised controlled trial—are the results dependent on the choice of labetalol or methyldopa?
Abstract
OBJECTIVE: To determine whether the difference in outcomes between 'less tight' (target diastolic blood pressure [dBP] of 100 mmHg) versus 'tight' control (target dBP of 85 mmHg) in the CHIPS Trial (ISRCTN 71416914, http://pre-empt.cfri.ca/;CHIPS) depended on the choice of labetalol or methyldopa, the two most commonly used antihypertensive agents in CHIPS.
DESIGN: Secondary analysis of CHIPS Trial data.
Authors
Magee L; Group TCS; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy K; Menzies J
Journal
BJOG An International Journal of Obstetrics & Gynaecology, Vol. 123, No. 7, pp. 1135–1141
Publisher
Wiley
Publication Date
June 2016
DOI
10.1111/1471-0528.13568
ISSN
1470-0328